• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节 p53 通路。

Modulating the p53 pathway.

机构信息

p53 Laboratory (A*STAR), 8A Biomedical Drive, Immunos, Singapore 138648, Singapore.

出版信息

Semin Cancer Biol. 2010 Feb;20(1):3-9. doi: 10.1016/j.semcancer.2010.02.004. Epub 2010 Mar 1.

DOI:10.1016/j.semcancer.2010.02.004
PMID:20193765
Abstract

p53 is a transcription factor that protects cells against stress, by modulating genes that induce growth arrest, repair, apoptosis, senescence or altered metabolism. Activation of p53 can potentially be used to modulate disease states. We describe here recent developments that attempt to modulate the function of p53 and outline strategies that are being investigated for pharmacological intervention in the p53 pathway. These include interruption of the interactions between p53 and its negative regulators, restabilization of mutant/misfolded p53, activation of p53 dependant transcription and modulation of p53 function systemically to affect the therapeutic profile of existing drugs. In addition the development of new animal models to investigate the above developments, including mice and zebrafish will be highlighted.

摘要

p53 是一种转录因子,通过调节诱导细胞生长停滞、修复、凋亡、衰老或改变代谢的基因来保护细胞免受应激。激活 p53 可能被用于调节疾病状态。我们在这里描述了最近的尝试调节 p53 功能的进展,并概述了正在研究的用于干预 p53 途径的药理学策略。这些策略包括中断 p53 与其负调节剂之间的相互作用、稳定突变型/错误折叠的 p53、激活 p53 依赖性转录以及系统性地调节 p53 功能以影响现有药物的治疗谱。此外,还将突出开发新的动物模型来研究上述进展,包括小鼠和斑马鱼。

相似文献

1
Modulating the p53 pathway.调节 p53 通路。
Semin Cancer Biol. 2010 Feb;20(1):3-9. doi: 10.1016/j.semcancer.2010.02.004. Epub 2010 Mar 1.
2
Current strategies to target p53 in cancer.针对癌症的 p53 靶向治疗策略。
Biochem Pharmacol. 2010 Sep 1;80(5):724-30. doi: 10.1016/j.bcp.2010.04.031. Epub 2010 May 5.
3
Classic and novel roles of p53: prospects for anticancer therapy.p53的经典与新角色:抗癌治疗的前景
Trends Mol Med. 2007 May;13(5):192-9. doi: 10.1016/j.molmed.2007.03.002. Epub 2007 Mar 23.
4
Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.分子神经肿瘤学与脑肿瘤靶向治疗策略的发展。第4部分:p53信号通路。
Expert Rev Anticancer Ther. 2005 Feb;5(1):177-91. doi: 10.1586/14737140.5.1.177.
5
[p53-regulating pathways as targets for personalized cancer therapy].[p53调控通路作为个性化癌症治疗的靶点]
Dtsch Med Wochenschr. 2013 Jan;138(3):82-6. doi: 10.1055/s-0032-1327380. Epub 2013 Jan 8.
6
The genetics of the p53 pathway, apoptosis and cancer therapy.p53信号通路、细胞凋亡与癌症治疗的遗传学
Nat Rev Drug Discov. 2008 Dec;7(12):979-87. doi: 10.1038/nrd2656.
7
Transcription-independent p53 apoptosis: an alternative route to death.转录非依赖的 p53 凋亡:通向死亡的另一种途径。
Trends Cell Biol. 2010 Jan;20(1):14-24. doi: 10.1016/j.tcb.2009.10.002. Epub 2009 Oct 30.
8
TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants.TAR1,一种人源抗 p53 单链抗体,可恢复突变型 p53 变异体的肿瘤抑制功能。
J Immunother. 2010 Feb-Mar;33(2):146-54. doi: 10.1097/CJI.0b013e3181be14dc.
9
The complex interactions of p53 with target DNA: we learn as we go.p53 与靶 DNA 的复杂相互作用:我们边研究边学习。
Biochem Cell Biol. 2003 Jun;81(3):141-50. doi: 10.1139/o03-046.
10
The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling.p53的促生存活性通过抑制c-Jun氨基末端激酶活性和线粒体死亡信号传导,保护细胞免受紫外线诱导的凋亡。
Cancer Res. 2004 Dec 1;64(23):8736-45. doi: 10.1158/0008-5472.CAN-04-2584.

引用本文的文献

1
Post-translational modification in the pathogenesis of vitiligo.白癜风发病机制中的翻译后修饰
Immunol Res. 2024 Dec;72(6):1229-1237. doi: 10.1007/s12026-024-09545-x. Epub 2024 Sep 25.
2
Knockdown of hCINAP sensitizes colorectal cancer cells to ionizing radiation.敲低 hCINAP 可增强结直肠癌细胞对电离辐射的敏感性。
Cell Cycle. 2024 Feb;23(3):233-247. doi: 10.1080/15384101.2024.2309015. Epub 2024 Mar 29.
3
Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53.发现具有 CDK2/p-RB 和 MDM2/p53 双重作用的新型抗肿瘤小分子药物。
Molecules. 2024 Feb 4;29(3):725. doi: 10.3390/molecules29030725.
4
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer.m6A 修饰在调控癌症中 PI3K/AKT 信号通路中的作用。
J Transl Med. 2023 Nov 1;21(1):774. doi: 10.1186/s12967-023-04651-0.
5
A multi-omics approach based on H-NMR metabonomics combined with target protein analysis to reveal the mechanism of RIAISs on cervical carcinoma patients.基于 H-NMR 代谢组学结合靶蛋白分析的多组学方法揭示 RIAISs 对宫颈癌患者的作用机制。
Aging (Albany NY). 2022 Sep 27;15(6):1878-1889. doi: 10.18632/aging.204305.
6
Value of glycogen synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells.糖原合酶 2 在肝内胆管癌预后评估中的价值及其对癌细胞活性的影响。
Bioengineered. 2021 Dec;12(2):12167-12178. doi: 10.1080/21655979.2021.2005224.
7
Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.Mdm2基因发生突变且该突变干扰MDM2与核糖体蛋白结合的小鼠,其红细胞生成出现缺陷。
PLoS One. 2016 Apr 4;11(4):e0152263. doi: 10.1371/journal.pone.0152263. eCollection 2016.
8
Molecular mechanisms of etoposide.依托泊苷的分子机制
EXCLI J. 2015 Jan 19;14:95-108. doi: 10.17179/excli2015-561. eCollection 2015.
9
Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling.肿瘤细胞 p53 状态对外源和内源凋亡信号的影响。
Cell Commun Signal. 2013 Apr 17;11(1):27. doi: 10.1186/1478-811X-11-27.
10
Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.通过葡萄糖限制来下调突变型 p53 水平的饮食调控:机制及对肿瘤治疗的影响。
Cell Cycle. 2012 Dec 1;11(23):4436-46. doi: 10.4161/cc.22778. Epub 2012 Nov 14.